Pharma
Vigilance
Signal Intelligence
GLP-1 Receptor Agonists
Semaglutide
Tirzepatide
Liraglutide
Jun 2023 – May 2024
Analysis current
Signal Table
Dashboard
Classification
All
◑ Under-characterized
⚠ Warning Signal
★ Point of Attention
· Low Signal
Priority
All
Critical
High
Medium
Low
Hide expected outcomes
⌕
Category
Signal / Adverse Effect ↕
Category ↕
Drug ↕
Classification ↕
Priority ↕
Mentions ↕
Severity ↕
Confidence ↕
FDA Label ↕
⚗
No signals match your current filters
Filters active:
✕ Clear all
Classification Breakdown
Click a segment to filter
✕ Clear
Priority Distribution
Click a bar to filter
✕ Clear
Signals by Drug
Click a bar to filter
✕ Clear
Signal Clusters
Click a bar to filter
✕ Clear
Top 15 Signals by Mention Volume
Click a bar to filter by that signal · color = priority level
✕ Clear
Signals
Signal
Category
Drug
Classification
Priority
Mentions
FDA Label
✕
Reddit Signal
Patient Evidence
FDA Comparison
Classification